latest news releases from the newsroom
Metro International: Proposal for The Board of Directors
BERTRANGE, Luxembourg, May 23, 2005 (PRIMEZONE) -- Metro International S.A. ("Metro"), the international newspaper group, today announced that The Nomination Group consisting of major shareholders of Metro International has agreed the following proposal to the Annual General Meeting the 31 May 2005.
ATA Airlines, Inc.
ATA Airlines Announces Sale Fares from Chicago-Midway
INDIANAPOLIS, May 23, 2005 (PRIMEZONE) -- ATA Airlines, Inc., subsidiary of parent company ATA Holdings Corp. (Pink Sheets:ATAHQ), announces a sale from Chicago-Midway to its most popular vacation and business destinations with domestic fares as low as $59(a) off-peak, each way and international fares as low as $149(a) off-peak, each way.
ATA Airlines, Inc.
ATA Airlines' Big Apple Sale Lets You Take a Take a Bite out of New York Without Taking a Bite out of your Wallet
INDIANAPOLIS, May 23, 2005 (PRIMEZONE) -- ATA Airlines, Inc., subsidiary of parent company ATA Holdings Corp. (Pink Sheets:ATAHQ), announces its "Big Apple Sale" with fares as low as $89(a) off-peak, each way from Chicago-Midway to New York (LGA) or Newark. Tickets may either be purchased on ata.com or by calling ATA reservations at 1-800-IFLYATA. The tickets require a seven-day advance purchase, and travel must be completed by October 28, 2005. The sale begins on May 23 and tickets must be purchased by May 31, 2005, at Midnight EDT.
Actelion Provides Update on Palosuran in Diabetic Nephropathy
ALLSCHWIL, Switzerland, May 23, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) announced today that preliminary efficacy data generated in the proof-of-concept program testing its urotensin-II receptor antagonist palosuran in the indication diabetic nephropathy, do not support the initiation of a full-fledged clinical development program at this point in time. The company will now fully analyze the data generated in three individual studies involving close to 100 patients and discuss the detailed findings with key medical experts in the field.
Texxon Incorporated Appoints New CEO
HOUSTON, May 22, 2005 (PRIMEZONE) -- Texxon, Inc. ("Texxon") (OTCBB:TXXN) today announced the appointment of Ben Hansel to Chief Executive Officer. Hansel will take over the reins as CEO and Chairman of the Board.